EUVIMEDEUVIMED entdecken
Crossref

Lysoglycosphingolipids have the ability to induce cell death through direct PI3K inhibition

Ryosuke Watanabe, Daisuke Tsuji, Hiroki Tanaka, Michael Shintaro Uno, Yukiya Ohnishi, Shindai Kitaguchi, Tsuyoshi Matsugu, Ryuto Nakae, Hiromi Teramoto, Kei Yamamoto, Yasuo Shinohara, Takatsugu Hirokawa und 3 weitere

Journal of Neurochemistry · 2023

DOI: 10.1111/jnc.16012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2023. Verfasst von Ryosuke Watanabe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Biotechnology, Graduate school of Pharmaceutical Science, Tokushima University, Tokushima, Japan. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Sphingolipidoses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sphingolipidoses are inherited metabolic disorders associated with glycosphingolipids accumulation, neurodegeneration, and neuroinflammation leading to severe neurological symptoms. Lysoglycosphingolipids (lysoGSLs), also known to accumulate in the tissues of sphingolipidosis patients, exhibit cytotoxicity. LysoGSLs are the possible pathogenic cause, but the mechanisms are still unknown in detail. Here, we first show that lysoGSLs are potential inhibitors of phosphoinositide 3‐kinase (PI3K) to reduce cell survival signaling. We found that phosphorylated Akt was commonly reduced in fibroblasts from patients with sphingolipidoses, including GM1/GM2 gangliosidoses and Gaucher's disease, suggesting the contribution of lysoGSLs to the pathogenesis. LysoGSLs caused cell death and decreased the level of phosphorylated Akt as in the patient fibroblasts. Extracellularly administered lysoGM1 permeated the cell membrane to diffusely distribute in the cytoplasm. LysoGM1 and lysoGM2 also inhibited the production of phosphatidylinositol‐(3,4,5)‐triphosphate and the translocation of Akt from the cytoplasm to the plasma membrane. We also predicted that lysoGSLs could directly bind to the catalytic domain of PI3K by in silico docking study, suggesting that lysoGSLs could inhibit PI3K by directly interacting with PI3K in the cytoplasm. Furthermore, we revealed that the increment of lysoGSLs amounts in the brain of sphingolipidosis model mice correlated with the neurodegenerative progression. Our findings suggest that the down‐regulation of PI3K/Akt signaling by direct interaction of lysoGSLs with PI3K in the brains is a neurodegenerative mechanism in sphingolipidoses. Moreover, we could propose the intracellular PI3K activation or inhibition of lysoGSLs biosynthesis as novel therapeutic approaches for sphingolipidoses because lysoGSLs should be cell death mediators by directly inhibiting PI3K, especially in neurons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesSphingolipidosesHumansMiceAnimalsPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktCell Death

Stichwörter der Autor:innen

PI3Kcell deathglycosphingolipidslipid mediatorsphingolipidoses

Substanzen

Phosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Medicinal Biotechnology, Graduate school of Pharmaceutical Science, Tokushima University, Tokushima, Japan.
  • Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan.
  • Faculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
  • Institute for Genome Research, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan.
  • Molecular Profiling Research Center for Drug Discovery (molprof), National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan.

ORCID-Profile: Kohji Itoh

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Watanabe, R., Tsuji, D., Tanaka, H., Uno, M. S., Ohnishi, Y., Kitaguchi, S., Matsugu, T., Nakae, R., Teramoto, H., Yamamoto, K., Shinohara, Y., Hirokawa, T., Okino, N., Ito, M., & Itoh, K. (2023). Lysoglycosphingolipids have the ability to induce cell death through direct PI3K inhibition. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16012

Vancouver

Watanabe R, Tsuji D, Tanaka H, Uno MS, Ohnishi Y, Kitaguchi S, et al. Lysoglycosphingolipids have the ability to induce cell death through direct PI3K inhibition. Journal of Neurochemistry. 2023. doi:10.1111/jnc.16012

BibTeX
@article{Watanabe2023,
  author = {Watanabe, Ryosuke and Tsuji, Daisuke and Tanaka, Hiroki and Uno, Michael Shintaro and Ohnishi, Yukiya and Kitaguchi, Shindai and Matsugu, Tsuyoshi and Nakae, Ryuto and Teramoto, Hiromi and Yamamoto, Kei and Shinohara, Yasuo and Hirokawa, Takatsugu and Okino, Nozomu and Ito, Makoto and Itoh, Kohji},
  title = {Lysoglycosphingolipids have the ability to induce cell death through direct PI3K inhibition},
  journal = {Journal of Neurochemistry},
  year = {2023},
  doi = {10.1111/jnc.16012}
}
Kostenlos starten →